Convening of the NAM Working Group on Technologies to Enhance Person, Family, & Community Engagement.
Convening of the NAM Artificial Intelligence (AI) and Machine Learning (ML) in Health Care Working Group and external experts to discuss a draft NAM Special Publication describing the promise, development, and deployment of AI/ML models to improve health.
The biannual meeting of the Care Culture and Decision-Making Innovation Collaborative will take place on December 6th, 2018.
The biannual members meeting of the Leadership Consortium for a Value & Science-Driven Health System occurred on Thursday, September 13th. The meeting centered around increasing consolidation in the health care industry and its implications for care culture, value, and evidence in a continuously learning health system.
Meeting Focus: Patient ownership of health data – implications for a learning health system. Motivating Questions: 1. Potential: Countless health data points are generated and collected daily in routine care and treatment, through research studies, by personal assessment and monitoring activities – yet only a tiny fraction are applied for care improvement or treatment discovery. If all health data could be available in a protected fashion for new insights, what might be the benefits for health care and health progress? 2. Barriers: To what extent are uncertainties about data ownership and control presenting a rate-limiting problem? How much do institutional competitive forces present an issue? Is the interpretation of institutional privacy regulations a barrier? 3. Ownership implications: If it is clear that individuals own their personal data, what access, control, and use protocols are necessary to facilitate data application for care improvement and discovery? How can the necessary infrastructure be supported? 4. Strategies: What issues and strategies take priority to catalyze transformative change? What are the stakeholder responsibilities, how can they be mobilized, and is there a constructive role for the National Academy of Medicine? Outcomes Anticipated: Establishment of a time-limited NAM Working Group to elaborate on issues, implications, and approaches for fostering patient data ownership and control of health data as a strategy for health progress.
This meeting of the Care Culture and Decision-Making Innovation Collaborative will focus on community health needs assessments as a means to activate communities in co-creating agendas to promote health and well-being.
Join us on April 25, from 2 – 3pm for the third and final webinar in Improving Care for High-Need Patients: A Webinar Series.
Join us on March 29, from 2 – 3pm for the second webinar in Improving Care for High-Need Patients: A Webinar Series.
The biannual members meeting of the Leadership Consortium for a Value & Science-Driven Health System occurred on Wednesday, March 21. The meeting centered around generating stakeholder demand and action for data sharing, linkage, and use for continuous learning.
Meeting Focus: Contributions of health services research (HSR) to effectiveness and efficiency in health and health care, and key priorities for HSR as a means of generating the evidence required to guide transformative progress in the next two decades. Core Questions: Contributions: How has HSR contributed to improvement in health gains and health care access, delivery, and quality—at various levels: system, organization, practice, and health-health care interfaces? Priorities: What are the challenges, opportunities, and priorities for HSR in the next decade, and beyond, for improving access, safety, quality, value, and patient/family engagement in a changing health care environment, while reducing spending growth and advancing population health progress? Support: What are the current public and private sources of support for HSR, what trends are in play, and do the metrics of decision-making and assessment vary by source and focus (e.g. technology assessment, clinical guidelines, care quality and safety, primary care, utilization and financing)? What should be the role of federal funding for HSR, now and in the long term? Organization: How are HSR opportunities identified? How is HSR funded, coordinated, and results disseminated? How might these processes be improved? What is or should be the profile of a governance structure for HSR? Statutory mandate: What might be the consequences if current legislative mandates related to HSR priorities—e.g. a Center on Primary Care Research and the Centers for Education and Research on Therapeutics (CERTs)—were eliminated? How might important emphases be sustained and nurtured? Intended Outcomes: Identify unique opportunities for the field of HSR to advance rigorous, timely, and relevant evidence, and inform national progress toward a health system that is person-centered, high performing, and continuously learning.